ask="N/A"
ask_size="N/A"
average_daily_volume="569148"
bid="N/A"
bid_size="N/A"
book_value="2.06"
change="+0.03"
change_from_200_day_moving_average="-0.04"
change_from_50_day_moving_average="0.09"
change_from_52_week_high="-5.90"
change_From_52_week_low="0.54"
change_in_percent="+2.22%"
close="1.38"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-138.84M"
eps_estimate_current_year="-0.71"
eps_estimate_next_quarter="-0.24"
eps_estimate_next_year="-1.39"
ex_dividend_date="N/A"
float_shares="38659000"
high="1.41"
high_52_weeks="7.28"
last_trade_date="1/3/2017"
last_trade_price="1.38"
last_trade_size="100"
last_trade_time="4:00pm"
low="1.32"
low_52_weeks="0.84"
market_capitalization="68.63M"
moving_average_200_day="1.42"
moving_average_50_day="1.29"
name="Infinity Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="6.67"
open="1.37"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-2.52%"
percent_change_from_50_day_moving_average="+6.60%"
percent_change_from_52_week_high="-81.04%"
percent_change_from_52_week_low="+64.25%"
previous_close="1.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.66"
price_per_sales="2.41"
revenue="27.80M"
shares_outstanding="49729000"
short_ratio="3.65"
stock_exchange="NMS"
symbol="INFI"
volume="190464"
weeks_range_52="0.84 - 7.28"
